June 30, 2026 · Phase 2 readout
CGTX Phase 2 readout: a positive outcome, +5.5%
On June 30, 2026, golexanolone — COGNITION THERAPEUTICS INC (Primary Biliary Cholangitis (PBC)) reached its Phase 2 readout. The result was a positive outcome, and the stock moved +5.5% in the window around the event. It had already run -5.1% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.
The move
$1.09
1d before
$1.15
Event day
$1.13
1d after
$1.17
5d after
Our prediction vs. the result
CatalystAlert called this one neutral (+0.6% expected); the stock actually moved +5.5%. Model confidence at the time: 40%.
See the full scored track recordPre-catalyst setup
-5.1%
30-day run-up
17264%
30-day volatility
0.9×
volume spike